Ren Jian-Song, Chen Wan-Qing, Shin Hai-Rim, Ferlay Jacques, Saika Kumiko, Zhang Si-Wei, Bray Freddie
Section of Cancer Information, International Agency for Research on Cancer, France.
Asian Pac J Cancer Prev. 2010;11(6):1587-94.
Knowledge of the cancer profile is an important step in planning rational cancer control programs and evaluation of their impact. Due to rapid changes in cancer incidence in China, national surveys may be insufficiently timely to provide adequate descriptions of the national burden. To evaluate the utility of cancer registries in describing the national cancer profile, this study compared two methods of estimating national cancer-specific incidence and mortality in China 2005, based on the Third National Death Survey (method I) as compared with registry material (method II). A total of 2.6 million cancer cases and 1.8 million cancer deaths were estimated by method I, as compared to 2.8 million cancer cases and 1.9 million cancer deaths using method II. The higher level of burden using the latter method in part may be due to a sizable differential in the magnitude of incidence rates across registries for certain cancer sites. Most cancer registries have been located in relatively more developed urban areas, or rural areas associated with higher risk for certain cancers. There are substantial differences in the cancer profile between urban and rural communities in China, and there may be concerns regarding the national representativeness of the data aggregated from this set of cancer registries. Timely and reliable estimation of cancer can only be realized if accurate information is available from cancer registries covering representative samples of the country.
了解癌症概况是规划合理的癌症控制项目及其效果评估的重要一步。由于中国癌症发病率变化迅速,全国性调查可能不够及时,无法充分描述全国癌症负担情况。为评估癌症登记处对于描述全国癌症概况的作用,本研究比较了两种估计2005年中国特定癌症发病率和死亡率的方法,一种基于第三次全国死因调查(方法I),另一种基于登记处资料(方法II)。方法I估计共有260万癌症病例和180万癌症死亡病例,而方法II估计有280万癌症病例和190万癌症死亡病例。后一种方法得出的负担水平较高,部分原因可能是某些癌症部位登记处的发病率在数值上存在相当大的差异。大多数癌症登记处位于相对发达的城市地区,或某些癌症风险较高的农村地区。中国城乡社区的癌症概况存在很大差异,因此可能有人担心从这组癌症登记处汇总的数据缺乏全国代表性。只有从覆盖全国代表性样本的癌症登记处获得准确信息,才能及时、可靠地估计癌症情况。